Collecting and Storing Tissue From Young Patients With Cancer

Inclusion Criteria: * All malignant tissues from childhood cancers allowed including the following: * Brain tumors (all types) * Tissue should be submitted to CNS Committee Resource labs to be forwarded for this study, unless instructed otherwise on the COG web site * Ewing family of tumors * Rhabdomyosarcomas * Other soft tissue sarcomas * Osteogenic sarcomas * Rhabdoid tumors * Neuroblastomas * Viable material for cell culture for neuroblastoma is collected via COG-ANBL00B1 and should not be submitted via this study unless the patient cannot be enrolled on COG-ANBL00B1\* * Retinoblastomas * Anaplastic Wilms tumor * Germ cell tumors * Leukemias/lymphomas * Acute myeloid leukemia (AML) * Blood samples and bone marrow samples from patients at second relapse and beyond may be submitted for this study * Bone marrow samples at diagnosis or first relapse must be submitted to an AML resource lab and will be forwarded for this study at the discretion of the AML Committee * Acute lymphoblastic leukemia (ALL) * Blood samples may be submitted directly to this study * Bone marrow samples must be submitted to an ALL resource lab and will be forwarded for this study at the discretion of the ALL Committee * Enrolled on a COG therapeutic, biology, or tissue banking protocol that allows collection of tissue for research and submission to a COG-designated resource laboratory * Participation in this protocol is not permitt…